Table 1.
Plasma samples | N | D1, N = 3 1 | D3, N = 15 1 | D9, N = 18 1 | D13, N = 15 1 | D21, N = 9 1 |
Positive RT-PCR | 60 | 2 (67%) | 8 (53%) | 2 (11%) | 0 (0%) | 0 (0%) |
RNA (copies/mL) | 12 | 916 [916; 917] | 267 [0; 886] | 95 [0; 190] | NA | NA |
Positive ELISA | 59 | 3 (100%) | 15 (100%) | 8 (47%) | 7 (47%) | 0 (0%) |
Antigen quantification (pg/mL) | 59 | 919 [12; 1412] | 165 [3; 9392] | 2 [0; 11,108] | 2 [0; 61] | 0 [0; 2] |
Urine samples | N | D1, N = 3 1 | D3, N = 12 1 | D9, N = 18 1 | D13, N = 14 1 | D21, N = 7 1 |
Positive RT-PCR | 14 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (%) | 0 (%) |
RNA (copies/mL) | 0 | NA | NA | NA | NA | NA |
Positive ELISA | 54 | 3 (100%) | 8 (67%) | 3 (17%) | 0 (0%) | 0 (0%) |
Antigen quantification (pg/mL) | 54 | 92 [38; 1651] | 18 [0; 254] | 0 [0; 1657] | 0 [0; 1] | 0 [0; 0] |
Respiratory samples | N | D1, N = 16 1 | D9, N = 1 1 | |||
Positive RT-PCR | 17 | 15 (94%) | 1 (100%) | |||
RNA (copies/mL) | 16 | 382,836 [210; 12,193,450] | 335 | |||
Positive ELISA | 17 | 15 (94%) | 1 | |||
Antigen quantification (pg/mL) | 17 | 2005 [0; 17,500] | 3 |
1 n (%); Median [Minimum; Maximum].